Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 51,199 $ 194,154
Restricted cash 2,231 828
Accounts receivable, net 389 2,080
Contract assets 464 3,077
Inventory 77,062 33,927
Due from related party 0 0
Prepaid expenses and other current assets 15,847 4,712
Total current assets 147,192 238,778
Property, plant and equipment, net 71,331 61,425
Right-of-use assets 14,539 14,685
Investments 6,812 13,498
Other non-current assets 930 3,354
Total assets 240,804 331,740
Current liabilities    
Accounts payable 21,926 10,334
Current portion of lease obligation 1,752 1,642
Current portion of provision for contract losses 11,775 0
Current portion of convertible debt 39,865 0
Accrued liabilities 24,972 23,790
Deferred revenue 20,414 12,150
Due to related party 718 42
Total current liabilities 121,422 47,958
Lease obligation, net of current portion 14,355 14,078
Deferred revenue, net of current portion 14,187 28,991
Related party convertible debt, net of current portion 39,534 0
Public and private placement warrant liabilities 2,596 20,188
Other long-term liabilities 290 7,555
Total liabilities 192,384 118,770
Commitments and contingencies (Note 17)
Stockholders’ equity (deficit)    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized; none issued and outstanding 0 0
Common stock, $0.0001 par value, 2,000,000,000 shares authorized; 337,710,003 and 334,919,914 shares issued and outstanding as of December 31, 2022 and 2021, respectively 34 34
Additional paid-in capital 1,060,117 1,033,393
Accumulated deficit (1,011,612) (820,454)
Accumulated other comprehensive loss (119) (3)
Total stockholders’ equity 48,420 212,970
Total liabilities and stockholders’ equity $ 240,804 $ 331,740